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Background: There are concerns about potential increasing use of over-the-counter (OTC) analgesics. The aims of
this study were to examine 1) the prevalence of self-reported use of OTC analgesics; 2) the prevalence of combining
prescription analgesics drugs with OTC analgesics and 3) whether lifestyle factors such as physical activity were
associated with prevalence of daily OTC analgesic use.
Methods: Questionnaire data from the Nord–Trøndelag health study (HUNT3, 2006–08), which includes data from
40,000 adult respondents. The questionnaire included questions on use of OTC analgesics, socioeconomic conditions,
health related behaviour, symptoms and diseases. Data were linked to individual data from the Norwegian Prescription
Database. A logistic regression was used to investigate the association between different factors and daily use of
paracetamol and/or non-steroid anti-inflammatory drugs (NSAIDs) in patients with and without chronic pain.
Results: The prevalence of using OTC analgesics at least once per week in the last month was 47%. Prevalence of
paracetamol use was almost 40%, compared to 19% and 8% for NSAIDs and acetylsalicylic acid (ASA), respectively.
While the use of NSAIDs decreased and the use of ASA increased with age, paracetamol consumption was unaffected
by age. Overall more women used OTC analgesics. About 3-5% of subjects using OTC analgesics appeared to combine
these with the same analgesic on prescription. Among subjects reporting chronic pain the prevalence of OTC analgesic
use was almost twice as high as among subjects without chronic pain. Subjects with little physical activity had 1.5-4
times greater risk of daily use of OTC compared to physically active subjects.
Conclusions: Use of OTC analgesics is prevalent, related to chronic pain, female gender and physical inactivity.
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In many countries, some analgesics are available over-
the-counter (OTC) without a prescription from a doctor.
Although OTCs are considered safe when used appro-
priately, intermittently and in the recommended doses,
they have the same hazards regardless of source of
supply. Not only is liver failure related to chronic unin-
tended overdose of paracetamol, but the safety of
chronic use of the drug was recently challenged [1]. Also* Correspondence: svetlana.skurtveit@medisin.uio.no
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unless otherwise stated.non-steroid anti-inflammatory drugs (NSAIDs) and
acetylsalicylic acid (ASA) pose gastrointestinal and car-
diovascular hazards as well as risk of serious interactions
with other drugs [2]. Therefore, the overall use of these
drugs may have significance for the general health of a
population, not least potential inappropriate use as indi-
cated by concomitant use of prescribed drugs and OTC
use of similar drugs [3].
Prevalence estimates for the use of OTC analgesics in
previous studies varied between countries [3-6]. Many of
these studies are 10–20 years old, different methodologies
and case definitions have been applied. In a survey from
2003, treatment of chronic pain, including prescription and
non-prescription analgesics, was investigated by interviewis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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European countries. Considerable differences in prevalence
of non-prescription medicines use between different
countries were observed in spite of applying the same
methodology across countries [7]. In a Norwegian population-
based study from 1986–87, comprising almost 20,000 in-
dividuals, it was found that 28% of women and 13% of
men had used analgesics in the past two weeks [5].
The following analgesics are available as OTC on the
Norwegian market: paracetamol; NSAIDs: ibuprofen, na-
proxen and diclofenac; ASA and phenazone. Paracetamol is
most widely used followed by ibuprofen. According to
wholesale data use of OTC analgesics increased in Norway
for 20 years until 2008, but has been stabilized last years [8].
Several factors have been shown to be associated with
analgesic use in the general population [4,5,9,10]. Exercise
is increasingly appreciated as an important factor that
benefits general public health, also among individuals suf-
fering from chronic pain [11], and therefore associations
between exercise and OTC use should be examined to-
gether with other lifestyle and socio-demographic factors.
Analgesic OTC may constitute a health hazard to public
health. Food and Drug Administration (FDA) has launched
a campaign to advice on safe use of these drugs [12]. Re-
search that discloses how analgesic OTC’s are used and by
whom may provide valuable knowledge for such cam-
paigns. In the present study, which is based on a major
questionnaire-based population study in Nord–Trøndelag
(HUNT3) linked to the complete national Norwegian Pre-
scription Database (NorPD), the following specific ques-
tions were addressed:
1. What is the prevalence of self-reported use of the
OTC group’s’ paracetamol, NSAIDs or ASA at least
once a week in the last month?
a. Overall, and in men and women
b. With age
c. Daily in the last month for muscle/joint pain or
headache
d. With chronic pain
e. With opioid use
2. What is the prevalence of prescribed analgesics 4, 6
and 8 weeks before entering the study among those
taking OTC analgesics at least once a week in the
last month?
a. How many subjects combine prescription
paracetamol with OTC paracetamol or
prescription NSAID with OTC NSAID?
3. Are lifestyle factors such as physical activity associated
with lower prevalence of daily OTC analgesic use?
Methods
Study design
A cross sectional descriptive study.Data sources
Population-based health survey Nord-Trøndelag (HUNT3)
All inhabitants aged 20 years or more in the county of
Nord-Trøndelag in Norway were invited to participate
in three population-based health surveys: the Nord-Trøndelag
Health Study (HUNT) 1, 2 and 3. The HUNT Study con-
stitutes a large population database for medical and
health-related research. HUNT3 was carried out in 2006–
2008, and a total of 93,860 individuals were invited to par-
ticipate (Figure 1). Participants were asked to complete
questionnaires. Questionnaire 1 (Q1) was mailed to them
together with an invitation to a physical examination. A total
of 50,805 participants returned Q1. Participants received
Questionnaire 2 (Q2) at the time of the physical examin-
ation and 41,204 individuals returned Q2 by mail (Figure 1).
Norwegian Prescription Database (NorPD)
NorPD contains information on all prescription drugs,
reimbursed or not, which are dispensed at pharmacies in
Norway to individuals outside institutions [13]. Each
record contains a unique person identifier, which makes
it possible to identify chronologically all prescriptions to
the individual subject. Prescription data are collected
from pharmacies, and thus only capture prescriptions
that are actually dispensed.
The two data sources HUNT3 and NorPD were linked
using the unique personal identity number assigned to
all individuals living in Norway.
Questionnaires
The data used in this study were obtained from Q1 and
Q2. Questionnaires are available at HUNT3 website
[14]. Two questions regarding pain from Q1 were in-
cluded: “Do you have bodily pain which has lasted for
more than 6 months?” and “How much bodily pain have
you had during the past month?” with the following re-
sponse options: “None, very mild, mild, moderate, severe
or very severe. Three questions addressed aspects of leis-
ure time physical activity: The average number of times
participants exercised per week, the average duration of
the exercise, and average intensity of each training ses-
sion”. The questions addressing exercise have shown ac-
ceptable test-retest reliability [15].
Two questions regarding use of OTC analgesics were
included in Q2 (Figure 2).
1) Question on type of OTC medicines and
2) Question on frequency of use for pain in headache
and pain in muscle/joints.
Lifestyle factors of interest were selected and cate-
gorised. Categories investigated were for smoking (non-
smoker, former smoker, and current smoker) and for
alcohol use last 12 month (non-consumer, 0-few times,
Figure 1 Flow chart of the study, Nord-Trøndelag Health Study (HUNT3).
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Age at date of physical examination in the health survey
was coded in 15-year categories.
Prescription drug use
Prescribed medicines dispensed at pharmacies in Norway
and recorded in NorPD are classified according to the
Anatomical Therapeutic Chemical (ATC) classification
system. Prescribed analgesics with the following ATC code
were included in the study: paracetamol (acetaminophen)
(N02BE01); acetylsalicylic acid (N02BA01), NSAIDs:
ibuprofen (M01AE01) and naproxen (M01AE02). In
addition, strong and weak opioids, which are classified
as ATC code N02A. Opioids are only available in Norway
on prescription. N02A includes all opioid analgesics
marketed in Norway, but not opioids primarily used in
anesthesia, substitution therapy of opioid addiction and
antitussives. In Norway only physicians are allowed to pre-
scribe analgesics.Definitions
Chronic pain was defined, as in previous studies, based
on the HUNT 3 study: report of pain lasting six months
or more and pain of at least moderate intensity during
the last week prior to participation in HUNT3 [11,16].
Persistent opioid use was defined based on data from
NorPD according to previously published criteria [17].
The broadest definition of persistent opioid use was ap-
plied in the present study, corresponding to use of
opioids several days a week or more often. Data on
dispensed opioid prescriptions during the 6 months im-
mediately prior to participation in HUNT3 and the
12 months after the participant’s first opioid prescription
were used for case definition.
Study population
Self-reported information for all 50,805 participants from
HUNT3 was linked to their prescription data from NorPD.
41,204 individuals returned Q2 by mail. Characteristics
ab
Figure 2 Two questions regarding use of over-the-counter (OTC) analgesics were included in Questionnaire 2 in population-based health surveys
in the the Nord-Trøndelag Health Study (HUNT3). a) Question on type of OTC medicines and b) Question on frequency of use for headache pain
and pain in muscle/joints.
Table 2 Self-reported use of over-the-counter (OTC)
analgesics at least once a week during the last month
according to type of drug
Paracetamol Acetylsalicylic acid Nonsteroidal
anti-inflammatory
agents (NSAIDs)
Responders, N 39,392 37,175 37,41
Women 22,024 20,491 20,775
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HUNT3 webside [18]. The question regarding the use
of OTC drugs in Q2 were answered by 37,175- 39,392
participants (Figure 1).
Analysis strategy and statistical analysis
The answers from the participants regarding use of over-
all OTC and different OTC analgesics at least once a
week in recent months (Figure 2, Tables 1 and 2) were
analysed. Participants who reported use of OTC analge-
sics were further investigated in relation to whether they
reported using these OTC drugs on a daily basis. The
questions “How often have you taken non-prescription
medicine for headache and/or pain in muscle/joints in
the last month” were used for this purpose. In the next
stage, use of OTC analgesics among participants withTable 1 Self-reported use of over-the-counter (OTC)
analgesics (paracetamol, acetylsalicylic acid or nonsteroidal
anti-inflammatory agents) at least once a week during
the last month
All Total Women Men
Responders, N 39,767 22,243 17,524
Users, N (%) 18,672 (47.0) 11,708 (52.9) 6,964 (39.7)
Chronic pain
Responders, N 11,761 7,252 4,508
Users, N (%) 7,543 (64.1) 5,081 (70.1) 2,462 (54.6)
No chronic pain
Responders 24,398 13083 11855
Users, N (%) 9,781 (39.2) 5,708 (43.8) 4,073 (34.6)and without reported chronic pain was investigated. Par-
ticipants with chronic pain were subsequently divided
into three categories regarding use of opioids: 1) persist-
ent users of opioids 2) non-persistent (intermittent)
users of opioids and 3) individuals who were not receiv-
ing opioids.Men 17,368 16,684 16,635
Users, N (%) 15,093 (38.3) 3,008 (8.1) 6,978 (18.7)
Women, N (%) 9,699 (44.0) 1,398 (6.8) 4,749 (22.9)
Men, N (%) 5,394 (31.1) 1,610 (9.6) 2,229 (13.4)
Daily users*, N (%) 1,598 (10.6) 376 (12.5) 746 (10.7)
Women*, N (%) 1,203 (12.4) 246 (17.6) 560 (11.8)
Men*, N (%) 395 (7.3) 130 (8.1) 186 (8.3)
Age years, N (%)
19-39 3,084 (39.7) 78 (1.0) 1,851 (24.0)
40-59 6,797 (40.1) 653 (4.1) 3,552 (21.6)
60-79 4,529 (35.0) 1,840 (15.4) 1,455 (12.3)
80+ 683 (39.8) 437 (27.9) 120 (4.9)
Daily use is related to pain in muscles/joints and /or headache.
*% of users.
Table 3 Self-reported use of over-the-counter (OTC)
analgesics at least once a week during the last month
among men and women stratified on chronic pain status
Paracetamol Acetylsalicylic acid Nonsteroidal
anti-inflammatory
agents (NSAIDs)
Chronic pain
Responders, N 11,548 10,452 10,619
Women 7,121 6,337 6,515
Men 4,427 4,115 4,104
Users, N 6,294 1,216 2,985
Women, N (%)* 4,322 (60.7) 638 (10.1) 2,143 (32.9)
Men, N (%)** 1,972 (44.5) 578 (14.0) 842 (20.5)
No chronic pain
Responders, N 24,788 23,898 23,984
Women 13,001 12,430 12,535
Men 11,787 11,468 11,449
Users, N 7,768 1,489 3,591
Women, N (%)* 4,666 (35.9) 587 (4.7) 2,313 (18.5)
Men, N (%)** 3,102 (26.3) 902 (7.9) 1,278 (11.2)
*% of women.
**% of men.
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analgesics, analyses were performed to determine whether
prescriptions of the same drug had been captured by NorPD
during 4, 6 and 8 weeks prior to self-reported use.
A logistic regression was used to investigate the associ-
ation between leisure time physical activity (frequency,
duration, intensity) and other lifestyle factors, socio-
demographic factors and health status and daily use of
paracetamol and/or NSAIDs in patients with and with-
out chronic pain. Unadjusted and adjusted odds ratios
(OR) with 95% confidence intervals were calculated.
Consent statement and ethics
All participants in HUNT3 were informed and gave con-
sents to participation in the main and follow-up studies.
All participants have consented to research being per-
formed on their data and to linking to other data sources.
The study was approved by the Regional Committee for
Medical and Health Research Ethics in Central Norway.
Linkage of databases was approved by the Norwegian Data
Protection Authority.
Results
Prevalence of use of OTC analgesics
The overall prevalence of consumption of OTC analge-
sics at last once per week in the last month was 47%
(Table 1). The prevalence was higher in those reporting
chronic pain (64.1%) compared to those without chronic
pain (39.2%). Women consistently reported higher preva-
lence compared to men.
The prevalence of self-reported use of the different
OTC analgesics at last once per week in the last month
was 38.3% for paracetamol, 18.7% for NSAIDs and 8.1%
for ASA (Table 2). The prevalence of use of all three
drug groups was higher (p < 0.001) in women compared
to men. The use of NSAIDs decreased with increasing
age, while ASA increased. The use of paracetamol was
not influenced by age. Furthermore, about 11% of users
of paracetamol, NSAIDs and ASA reported daily use of
OTC analgesics for pain in muscles/joints during the
last month.
Use of OTC analgesics and reports of chronic pain
Subjects reporting chronic pain reported almost twice
as high prevalence of use of paracetamol, NSAIDS and
ASA (Table 3). Regardless of pain status, women (p < 0.001)
used these drugs more frequently than men, except for
ASA (p < 0.001).
Use of OTC analgesics and prescription analgesics
When the study population was stratified with regard to
the level of opioid use and whether they reported
chronic pain or not, prevalence of OTC analgesic use
was highest in persons with non-persistent (intermittent)opioid use and chronic pain (Table 4). A lower preva-
lence was observed in persons with persistent opioid use
and chronic pain, and lowest in persons with no opioid
use and chronic pain. However, the prevalence in all
these three groups was approximately twice as high as in
persons without chronic pain. These patterns were the
same for all three groups of OTC analgesics.
Figures for concomitant use of OTC analgesics and
prescriptions of the same group of analgesics were simi-
lar for paracetamol and NSAIDs: about 3, 4 and 5% had
received prescriptions for the same group of analgesics
during the last 4, 6 and 8 weeks, respectively, before
HUNT 3 data collection (Table 5). 385 subjects had con-
comitant prescriptions for two different NSAIDS, while
440 and 196 subjects had concomitantly reported pre-
scribed and OTC paracetamol and NSAIDs (results not
shown), respectively.
Associations between use of OTC analgesics and health/
lifestyle factors
The most important risk factor related to physical activ-
ity for using analgesics on a daily basis was exercise of
short duration (Table 6). The risk (adjusted OR) was 1.5
and 4 times higher for daily use in chronic and non-
chronic pain respondents in this group, respectively.
Positive associations were observed between daily use of
OTC analgesics and increasing age, female gender, head-
ache and increasing pain intensity. Interestingly, con-
sumption of alcohol 2–7 times per week reduced the
Table 4 Self-reported use of over-the-counter (OTC) analgesics among chronic pain patients related to their prescribed
opioid use
Chronic pain -persistent
users of opioids
Chronic pain - non persistent
users of opioids
Chronic pain- not
receiving opioids
Non Chronic pain
Paracetamol, N (%) 221 (63.5) 1,043 (71.5) 5,030 (51.6) 7,768 (31.3)
Acetylsalicylic acid, N (%) 35 (11.6) 206 (16.2) 975 (11.0) 1489 (6.2)
Nonsteroidal anti-inflammatory
agents (NSAIDs), N (%)
91 (29.6) 457 (35.8) 2437 (27.0) 3591 (15.0)
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with chronic pain (OR = 0.7), compared to non-consumers.
Discussion
This is the first study combining self-reported use of
OTC analgesics from a large general population sample
and prescription data from a complete national prescrip-
tion database. The main finding was that the prevalence
of using OTC analgesics at least once per week in the
last month was 47%. Paracetamol was used by almost
40% of subjects, approximately two and four times as
prevalent as NSAIDs and ASA, respectively. Among
subjects reporting use of OTCs for muscle/joint pain,
paracetamol, NSAIDS and ASA were consumed daily by
11% of the subjects. The use of NSAIDs decreased with
age, whereas use of ASA increased in the older popula-
tion. Subjects who carried out minimal physical activity,
regardless of reported pain status, had 1.5-4 times
greater risk of daily use of OTC. Possible concomitant
use of OTC and prescribed paracetamol or NSAIDS an-
algesics varied between 2.8 and 5.2%.
Prevalence compared to previous studies
Compared to previous Norwegian reports of a two-week
periodic prevalence of OTC analgesic use of 28% in
women and 13% in men [5] it appears that the use of
OTC analgesics have increased substantially in Norway.
However, even higher prevalence estimates have been re-
ported from other countries. In a study of the US adult
population from 1988 to the last month prevalence of use
was 76% for non-prescription analgesics [6]. On the other
hand some European studies showed lower prevalence in
the use of OTC analgesics than in our study. In a Scottish
study from 2005, which studied use during the preceding
two weeks, a prevalence of 37% OTC analgesics was foundTable 5 Frequencies of individuals with prescription on parace
agents (NSAIDs) among those reporting use of the same over-t
to study start
Self-reported use, N Self-reported use + dru
dispensed during 4 we
prior to study start, N
Paracetamol 15,093 440 (2.9)
Acetylsalicylic acid 3,008 0 (0)
NSAIDs 6,978 196 (2.8)[10]. Antonov and Isacson studied the prevalence of anal-
gesic use in Sweden in 1998 and reported the two-week
prevalence to be approximately 25% for OTC analgesics
[4,9]. It must, however, be noted that direct comparison of
prevalence estimates is difficult due to the differences in
methodologies, recall times and case definitions.
In the present study, paracetamol was the dominating
OTC drug regardless of gender and age. This was also
the case for US study [6], which reported a prevalence of
non-prescription analgesic use in the past month for
paracetamol, ibuprofen and ASA to be around 40%,
38% and 24%. In a survey on chronic pain in European
countries, use of different non-analgesics varied between
countries. Non-prescription paracetamol was more fre-
quently used in Denmark, The Netherlands, Poland,
Sweden and Norway, whereas use of NSAIDs was pre-
dominant in Finland, Austria, Germany and Italy [7].
The variations are most likely attributable to cultural dif-
ferences and differences in therapeutic traditions. Never-
theless, in both studies the Norwegian population had a
higher prevalence of paracetamol use and a lower preva-
lence of NSAIDs, in particular ASA, and current prac-
tice in Norway is in line with a regulatory decision from
the 1980s to switch OTC analgesic use from ASA to
paracetamol for reasons of public safety.
Gender aspect
It is generally agreed that women use more non-prescription
analgesics than men and this is also confirmed at all
levels in the present study [4-6,9]. This finding is prob-
ably related to findings of a higher prevalence of chronic
non-malignant pain in women compared to men [19].
However, results from a Finnish study [3] did not show
any obvious gender difference in analgesic use by the
general population in 2002. In the Finnish study it wastamol, acetylsalicylic acid or nonsteroidal anti-inflammatory
he-counter (OTC) analgesics during 4, 6 and 8 weeks prior
g
eks
(%)
Self-reported use + drug
dispensed during 6 weeks
prior to study start, N (%)
Self-reported use + drug
dispensed during 8 weeks
prior to study start, N (%)
629 (4.2) 777 (5.1)
1 (0.03) 1 (0.03)
278 (4.0) 366 (5.2)
Table 6 Multivariate analysis of the association (odds ratio; OR with 95% confidence interval) between physical
activity, socio demographic, lifestyle characteristics, headache, opioid use for chronic pain, pain intensity and daily
use of paracetamol and/or nonsteroidal anti-inflammatory agents (NSAIDs) in persons without and with chronic pain
Without chronic pain Chronic pain
unadjusted OR (95% CI) adjusted OR (95% CI) unadjusted OR (95% CI) adjusted OR (95% CI)
Physical activity
Physical activity-frequency
non-excercise 1.3 (0.9-1.9) 0.5 (0.3-1.0) 1.4 (1.2-1.7) 1.0 (0.8-1.3)
once/week 1.2 (0.8-1.8) 0.6 (0.4-1.0) 1.2 (1.0-1.5) 0.9 (0.7-1.2)
2-3 times/week 0.9 (0.6-1.3) 0.6 (0.4-1.0) 1.1 (0.9-1.3) 1.0 (0.8-1.2)
> = 4 times /week 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Physical activity- duration
0-30 minutes 4.1 (2.3-7.1) 4.0 (1.9-8.4) 2.0 (1.6.2.4) 1.5 (1.1-2.0)
30-60 minutes 2.6 (1.5-4.3) 2.7 (1.5-5.1) 1.2 (1.0-1.5) 1.1 (0.9-1.4)
> = 60 minutes 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Physical activity- intensity
light 6.1 (1.5-24.7) 1.7 (0.4-7.0) 3.0 (1.5-5.8) 2.0 (0.9-4.5)
moderate 2.3 (0.6-9.3) 1.0 (0.2-4.3) 1.8 (0.9-3.5) 1.7 (0.8-3.7)
hard 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Gender
men 1 (reference) 1 (reference) 1 (reference) 1 (reference)
women 2.4 (1.5-4.0) 2.4 (1.63.4) 1.9 (1.7-2.2) 1.8 (1.5-2.1)
Age , years
19-39 1 (reference) 1 (reference) 1 (reference) 1 (reference)
40-59 2.0 (1.2-3.1) 2.3 (1.3-4.0) 1.5 (1.2-1.9) 1.7 (1.3-2.2)
60-80 3.8 (2.4-6.0) 5.1 (2.9-0.0) 2.1 (1.6-2.6) 2.5 (1.9-3.3)
80+ 9.9 (5.7-17.0) 11.3 (5.4-23.9) 3.2 (2.4-4.3) 3.5 (2.3-5.2)
Smoke
non-smoker 1 (reference) 1 (reference) 1 (reference) 1 (reference)
former smoker 1.1 (0.8-1.5) 1.1 (0.8-1.6) 1.0 (0.9-1.1) 1.0 (0.9-1.2)
current smoker 1.2 (0.8-1.6) 1.2 (0.8-1.8) 1.3(1.1-1.5) 1.4 (1.1-1.6)
Alcohol (frequency last 12 months)
non-consumer 1 (reference) 1 (reference) 1 (reference) 1 (reference)
0- few times 0.6 (0.5-1.1) 1.0 (0.5-2.0) 0.8 (0.6-1.0) 0.7 (0.5-1.0)
once per month - once per week 0.4 (0.2-0.7) 0.9 (0.5-1.8) 0.5 (0.4-0.6) 0.7 (0.5-1.0)
2-7 times per week 0.2 (0.1-0.5) 0.5 (0.3-1.2) 0.5 (0.4-0.6) 0.7 (0.5-0.9)
Headache last 12 month
no 1 (reference) 1 (reference) 1 (reference) 1 (reference)
yes 2.0 (1.5-2.6) 2.1 (1.5-3.0) 1.6 (1.4-1.8) 1.6 (1.4-1.8)
Opioid use for chronic pain
no use 1 (reference) 1 (reference) 1 (reference) 1 (reference)
occasional * * 3.0 (3.8-6.0) 2.1 (1.8-2.5)
persistent * * 4.7 (3.8-6.0) 2.6 (1.9-3.5)
Pain intensity
no pain 1 (reference) 1 (reference) *
very mild 1.9 (1.2-3.0) 1.7 (1.0-3.1) *
mild 4.9 (3.4-7.0) 5.1 (3.3-7.9) *
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Table 6 Multivariate analysis of the association (odds ratio; OR with 95% confidence interval) between physical
activity, socio demographic, lifestyle characteristics, headache, opioid use for chronic pain, pain intensity and daily
use of paracetamol and/or nonsteroidal anti-inflammatory agents (NSAIDs) in persons without and with chronic pain
(Continued)
moderate 3.5 (2.3-5.5) 3.5 (2.0-6.0) 1 (reference) 1 (reference)
strong 9.4 (5.5-16.3) 9.4 (4.7-18.9) 3.0 (2.7-3.4) 2.5 (2.1-2.9)
very strong 15.4 (5.9-39.7) 30.1 (10.8-84.1) 5.0 (3.8-6.4) 4.8 (3.4-6.8)
*not relevant.
number of cases in the adjusted analyses: non chronic pain n = 20 648 ; chronic pain n = 9 130.
significant results are shown in bold text.
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algesics and prescribed analgesics in men whereas
women dominated the “a few times per week” group.
This observation clearly differs from our own, in which
a much higher proportion of women reported daily use
of OTC analgesics, compared to men. Cultural factors
may explain observed differences.
Age
In an earlier Norwegian study [5], no relation to age was
found. A Swedish study showed that individuals in the
age group 18–44 years had the highest prevalence [9]. In
our study, after controlling for confounding variables, a
higher risk of daily use of OTC analgesics was found
among older participants, both with and without chronic
pain. When we studied each of the drugs used separately
at least once per week in the last month, paracetamol
use was age-independent, while ASA use increased with
age. The use of NSAIDs decreased with age. The latter
is an important observation as it complies with guide-
lines and recommendations asking for restrictive use of
NSAIDs in the elderly population.
Pain and opioid use
Pain intensity was a very strong predictor of OTC analgesic
use in subjects with both chronic and non-chronic pain.
The prevalence of OTC analgesic use was higher in persons
reporting chronic pain who were non-persistent (intermit-
tent) users of opioids, compared to those with chronic pain
who were persistent users of opioids. A likely explanation is
that the former group used OTC analgesics more regularly
and substituted or supplemented with opioids in periods of
exacerbations, while the latter did the opposite.
Exercise and other lifestyle factors
Those subjects who reported little or no physical activity
had a higher risk of using daily non-prescription analge-
sics than those who were active. Poor physical condition
was a risk factor for analgesic use in the Swedish study
[9], as well as for men only in an earlier Norwegian
study [5]. Furthermore, alcohol consumption and smok-
ing was positively related to analgesic use [9]. In the
present study, smoking increased the risk of using non-prescription analgesics on a daily basis in chronic pain
subjects, while frequent alcohol use had the opposite ef-
fect. It spite of no analgesic effects it can be speculated
that self-medication with alcohol is a substitute for anal-
gesic use. Differences between studies may reflect cul-
tural and social changes over a 25- year period.Combination of prescription, non-prescription non-opioid
analgesics
In the present study it was shown that possible concomi-
tant use of OTC analgesics and prescribed paracetamol or
NSAIDS varied between 2.8% and 5.2% depending on the
duration (4, 6 or 8 weeks) of the study period. Overlapping
use of both prescribed and OTC analgesics may increase
the risk of interactions and overdosing [3]. Therefore phy-
sicians, when prescribing analgesics, should warn their pa-
tients against such drug combinations.Limitations and strengths
Strength of the present study was the use of a complete
national prescription database where data are not influ-
enced by recall bias. Another strength is the size of the
population included. Subjects responded to detailed
questions regarding the use of OTC drugs and a number
of other potential confounders including validated ques-
tions on chronic pain and physical activity. However, the
response rate was only about 50%. Even though the
study population in HUNT3 is considered fairly repre-
sentative of the Norwegian population, a non-responder
study reported higher prevalence of musculoskeletal pain
in participants compared to non-participants [20]. On
the other hand a previous study of the use of opioid an-
algesics found that the prevalence of persistent opioid
use was 1.0% percent in the HUNT3 population compared
to 1.1% in the general Norwegian population, indicating
that the HUNT3 participants are fairly representative with
regard to analgesic use [21]. HUNT3 data were collected
during 2006 to 2008 and it can be questioned whether pat-
terns of drug use might have changed since then. How-
ever, the wholesale data have been fairly stable since 2008,
indicating that findings from the HUNT3 study still have
a high validity [8].
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The finding that 47% of those participating in the large
and representative population survey used OTC analge-
sics at least once a week during the last month, demon-
strates that such drug use is more prevalent than the
self-reporting of chronic non-malignant pain of moder-
ate or higher intensity, which in Norway is estimated to
be around 30%. This indicates that mild but recurrent
pain might not be detected by definitions of chronic pain
in spite of leading to analgesic use. The finding that ap-
proximately 11% of those using OTC analgesics used
these drugs on a daily basis raises some concerns that
health care personnel need to be aware of. Long term
analgesic treatment should only be commenced after a
physician has considered the anticipated effect, side ef-
fects and risks of interactions. If long-term treatment is
indicated the physician should prescribe these drugs
instead of approving long-term OTC use. Switching
to prescriptions will give the physician better control,
which is in the best interest of the patient. The present
findings imply that doctors should ask for OTC anal-
gesic use, and in cases of daily use the doctor should if
treatment is indicated switch to prescription use, and if
not, advise to terminate or substantially reduce the OTC
analgesic use.
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